Can a widely accessible vaccine reduce Alzheimer’s risk?
A recent study published in Neurology suggests that high-dose flu vaccines may lower the risk of Alzheimer’s disease in adults over 65, especially women, with benefits observed for up to two years post-vaccination.
In a recent Neurology-published study, scientists have discovered a connection between flu vaccine dosing and Alzheimer’s risk in adults over 65 years of age.
The researchers analyzed more than 160,000 individuals over 65 with no cognitive impairment at the start of the trial. Most of the participants received a high-dose flu vaccine, while about 44,022 received the standard dose. After being followed up with for three years, the researchers found that the group who received the high dose had a lower chance of developing Alzheimer’s for about two years after getting vaccinated, particularly the women participants.
